Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Volker Heinemann

Showing results (1-10 of 384) with videos related to

Pageof 39
Sort By:
Seminars in Oncology|March 15, 2002
Gemcitabine-based combination treatment of pancreatic cancerVolker Heinemann
Seminars in Oncology|July 3, 2002
Present and future treatment of pancreatic cancerVolker Heinemann
Oncology|April 17, 2003
Role of gemcitabine in the treatment of advanced and metastatic breast cancerVolker Heinemann
Clinical Breast Cancer|June 12, 2002
Gemcitabine plus cisplatin for the treatment of metastatic breast cancerVolker Heinemann
Seminars in Oncology|February 11, 2003
Gemcitabine in the treatment of advanced pancreatic cancer: a comparative analysis of randomized trialsVolker Heinemann
Expert Review of Anticancer Therapy|July 9, 2005
Gemcitabine in metastatic breast cancerVolker Heinemann
Cancer Discovery|June 4, 2015
Sym004: Truly a New Level of Anti-EGFR Treatment?Sebastian Stintzing, Volker Heinemann
Deutsche Medizinische Wochenschrift (1946)|November 6, 2021
[Neoadjuvant and adjuvant therapy of resectable colon cancer - Current standards and developments]Volker Heinemann, Sebastian Stintzing
Clinical Colorectal Cancer|May 27, 2008
Cetuximab plus XELIRI or XELOX for first-line therapy of metastatic colorectal cancerNicolas Moosmann, Volker Heinemann
Expert Review of Anticancer Therapy|March 28, 2008
Cetuximab plus oxaliplatin-based chemotherapy in the treatment of colorectal cancerNicolas Moosmann, Volker Heinemann
Pageof 39

Showing results (1-10 of 384) with videos related to

Sort By:
Pageof 39
Seminars in Oncology|March 15, 2002
Gemcitabine-based combination treatment of pancreatic cancerVolker Heinemann
Seminars in Oncology|July 3, 2002
Present and future treatment of pancreatic cancerVolker Heinemann
Oncology|April 17, 2003
Role of gemcitabine in the treatment of advanced and metastatic breast cancerVolker Heinemann
Clinical Breast Cancer|June 12, 2002
Gemcitabine plus cisplatin for the treatment of metastatic breast cancerVolker Heinemann
Seminars in Oncology|February 11, 2003
Gemcitabine in the treatment of advanced pancreatic cancer: a comparative analysis of randomized trialsVolker Heinemann
Expert Review of Anticancer Therapy|July 9, 2005
Gemcitabine in metastatic breast cancerVolker Heinemann
Cancer Discovery|June 4, 2015
Sym004: Truly a New Level of Anti-EGFR Treatment?Sebastian Stintzing, Volker Heinemann
Deutsche Medizinische Wochenschrift (1946)|November 6, 2021
[Neoadjuvant and adjuvant therapy of resectable colon cancer - Current standards and developments]Volker Heinemann, Sebastian Stintzing
Clinical Colorectal Cancer|May 27, 2008
Cetuximab plus XELIRI or XELOX for first-line therapy of metastatic colorectal cancerNicolas Moosmann, Volker Heinemann
Expert Review of Anticancer Therapy|March 28, 2008
Cetuximab plus oxaliplatin-based chemotherapy in the treatment of colorectal cancerNicolas Moosmann, Volker Heinemann
Pageof 39